Look: Mylan N.V. (MYL) shares slip following expanded recall of auto-injection

http://ift.tt/2ouoaau

Healthcare giant Mylan N.V. (NASDAQ: MYL) with a market cap of $20.88 billion, ended March with magnified efforts to recall EpiPen Auto-Injectors. The stock closed $38.99 on March 31, or a decrease of 1.52% on above-average trading volume. What initially began as a voluntary recall for select lots...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

April 03, 2017 at 10:57PM

http://ift.tt/2nTyUxS

from Kristine Esperacion

http://ift.tt/2nTyUxS